HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
The Week

The Top Pharmacy Benefit Managers of 2025: Market Share and Key Industry Developments (rerun)

This week, we're rerunning some popular posts while we prepare for Friday's live video webinar: 340B in 2026: Market Shifts, Policy Battles, and What They Mean for Stakeholders. Click here to see the original post from March 2026. By Adam J. Fein, Ph.D.Three is still the magic number for pharmacy be

By Drug Channels · Jun 9, 2026 · via Drug Channels

This is an aggregated industry headline. Read the full story at Drug Channels →

Tags
theweekformat:headlineheadlineDrug Channels
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The Oral GLP-1 Tracker: Novo's oral Wegovy hits 3M prescription milestone as Lilly's Foundayo chugs along in early launch
The WeekFiercePharma ↗
The Oral GLP-1 Tracker: Novo's oral Wegovy hits 3M prescription milestone as Lilly's Foundayo chugs along in early launch
Fierce Pharma is launching the weekly Oral GLP-1 Tracker, leveraging analysts' notes and IQVIA data to monitor…
Jun 9, 2026
Bial bails after Parkinson's fail, axing asset over phase 2 miss
The WeekFierceBiotech ↗
Bial bails after Parkinson's fail, axing asset over phase 2 miss
Bial has stopped development in a subpopulation of Parkinson's disease patients after its phase 2b trial misse…
Jun 9, 2026
ResMed buys Noctrix Health for $340M, widening its sleep-tech reach
The WeekBriefing
ResMed buys Noctrix Health for $340M, widening its sleep-tech reach
The sleep and respiratory giant completed the $340M Noctrix acquisition, adding a wearable neuromodulation tre…
Jun 9, 2026